The medtech firm will search regulatory approval within the US for its gadget treating end-of-life most cancers sufferers on the finish of 2025.
Galway-based start-up SymPhysis Medical has obtained €2.2m in funding, which it should use to hold out pre-clinical research for its medical gadget.
The funding consists of follow-on investments from Irrus Investments, the MedTech Syndicate and Boole Investments together with capital from Enterprise Eire and a brand new personal investor.
A earlier SiliconRepublic.com Begin-up of the Week, the corporate was based by CEO Tim Jones and chief scientific officer Dr Michelle Tierney.
The beginning-up has developed a tool that addresses malignant pleural effusion – a build-up of fluid between the chest wall and the lung, which might happen in late-stage most cancers sufferers.
This fluid can go away these affected feeling wanting breath or experiencing chest discomfort and is a typical incidence for end-of-life most cancers sufferers.
SymPhysis Medical’s gadget guarantees a much less invasive different to present remedies and could be managed from a affected person’s dwelling, giving sufferers extra freedom.
The newest funding will assist the corporate to launch within the US and attain its first sufferers. A part of these plans embody getting approval from the Meals and Drug Administration (FDA) by the tip of 2025.
Jones mentioned the start-up’s focus has at all times been on enhancing sufferers’ high quality of life as they obtain palliative care.
“We’re excited to be attending to the purpose after we can lastly see our gadget benefiting sufferers. This is able to not have been doable with out the help of our traders, who’ve seen that that is an unmet scientific want with international market potential,” he mentioned.
“Now we have additionally been capable of display to them that this can be a gadget with the help of worldwide leaders in most cancers care, so there is no such thing as a query in regards to the urge for food for it – it’s all about getting it to our first sufferers as quickly as doable.”
SymPhysis Medical’s newest funding follows a €1.5m fund increase in December 2023, which it had deliberate to make use of on rising its crew. The corporate additionally received the Collaboration in Medtech Award on the Irish Medtech Awards that very same month.
Don’t miss out on the information you might want to succeed. Join the Each day Temporary, Silicon Republic’s digest of need-to-know sci-tech information.
